Y Intercept Hong Kong Ltd Makes New $461,000 Investment in Inspire Medical Systems, Inc. (NYSE:INSP)

Y Intercept Hong Kong Ltd acquired a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,488 shares of the company's stock, valued at approximately $461,000.

Other large investors also recently bought and sold shares of the company. Wealthspire Advisors LLC bought a new position in shares of Inspire Medical Systems in the 4th quarter worth about $402,000. First Horizon Advisors Inc. lifted its holdings in Inspire Medical Systems by 885.7% in the fourth quarter. First Horizon Advisors Inc. now owns 138 shares of the company's stock worth $26,000 after acquiring an additional 124 shares during the last quarter. Ieq Capital LLC lifted its holdings in Inspire Medical Systems by 781.5% in the fourth quarter. Ieq Capital LLC now owns 21,095 shares of the company's stock worth $3,911,000 after acquiring an additional 18,702 shares during the last quarter. TimesSquare Capital Management LLC acquired a new position in Inspire Medical Systems in the fourth quarter valued at approximately $80,419,000. Finally, Principal Financial Group Inc. grew its holdings in shares of Inspire Medical Systems by 3.7% during the fourth quarter. Principal Financial Group Inc. now owns 146,310 shares of the company's stock valued at $27,123,000 after purchasing an additional 5,221 shares during the last quarter. Institutional investors own 94.91% of the company's stock.

Insiders Place Their Bets

In other news, insider Randy Ban sold 25,584 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the completion of the sale, the insider now owns 7,259 shares in the company, valued at approximately $1,332,026.50. This represents a 77.90 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO John Rondoni sold 583 shares of Inspire Medical Systems stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total value of $99,395.67. Following the completion of the transaction, the chief technology officer now owns 10,424 shares in the company, valued at $1,777,187.76. The trade was a 5.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 26,225 shares of company stock worth $4,806,530. 4.10% of the stock is owned by corporate insiders.

Remove Ads

Analyst Ratings Changes

Several analysts recently issued reports on INSP shares. Royal Bank of Canada reissued an "outperform" rating and issued a $260.00 price target on shares of Inspire Medical Systems in a report on Tuesday, February 11th. Wells Fargo & Company reduced their price target on shares of Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating for the company in a report on Tuesday, February 11th. KeyCorp restated an "overweight" rating and set a $234.00 price target (down previously from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Bank of America upgraded shares of Inspire Medical Systems from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Finally, Truist Financial decreased their target price on shares of Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating for the company in a research report on Tuesday, February 11th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, Inspire Medical Systems currently has a consensus rating of "Moderate Buy" and an average price target of $228.82.

Inspire Medical Systems Price Performance

Shares of Inspire Medical Systems stock traded up $2.16 on Thursday, hitting $178.36. The company had a trading volume of 168,632 shares, compared to its average volume of 575,510. Inspire Medical Systems, Inc. has a 52 week low of $123.00 and a 52 week high of $257.40. The company has a market cap of $5.29 billion, a PE ratio of 103.16, a PEG ratio of 2.86 and a beta of 1.48. The business has a 50-day simple moving average of $187.46 and a 200-day simple moving average of $192.90.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings results on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. On average, equities research analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.